Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Net Cash Flow (2016 - 2026)

MedWellAI has reported Net Cash Flow over the past 12 years, most recently at -$85718.0 for Q4 2025.

  • Quarterly Net Cash Flow rose 83.36% to -$85718.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$185796.0 through Dec 2025, down 189.73% year-over-year, with the annual reading at $254715.0 for FY2025, 227.24% up from the prior year.
  • Net Cash Flow was -$85718.0 for Q4 2025 at MedWellAI, up from -$178089.0 in the prior quarter.
  • Over five years, Net Cash Flow peaked at $2.0 million in Q2 2021 and troughed at -$1.4 million in Q3 2021.
  • The 5-year median for Net Cash Flow is -$69957.5 (2022), against an average of -$216.45.
  • Year-over-year, Net Cash Flow soared 2210.21% in 2021 and then tumbled 1604.92% in 2024.
  • A 5-year view of Net Cash Flow shows it stood at -$531609.0 in 2021, then soared by 89.81% to -$54197.0 in 2022, then surged by 44.24% to -$30220.0 in 2023, then tumbled by 1604.92% to -$515226.0 in 2024, then soared by 83.36% to -$85718.0 in 2025.
  • Per Business Quant, the three most recent readings for MWAI's Net Cash Flow are -$85718.0 (Q4 2025), -$178089.0 (Q3 2025), and -$169691.0 (Q2 2025).